ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer and infectious disease. ADVENTRX seeks to improve the performance and commercial potential of existing treatments by addressing limitations associated with these treatment regimens.

Our goal is to be a leading biopharmaceutical company focused on in-licensing, developing and commercializing proprietary p... More >>

Recent News

More >>

Date Title   03/01/10 ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application 02/04/10 ADVENTRX Announces Management Promotions 02/03/10 ADVENTRX Appoints Icahn Representative to Board of Directors 02/02/10 ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9

Upcoming Events

More >>

There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.